MetLife Investment Management’s Sabre SABR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$271K Buy
186,762
+29,834
+19% +$39.7K ﹤0.01% 2070
2025
Q4
$213K Sell
156,928
-35,772
-19% -$61.6K ﹤0.01% 2241
2025
Q3
$353K Sell
192,700
-21,613
-10% -$51K ﹤0.01% 1992
2025
Q2
$677K Buy
214,313
+8,943
+4% +$22.9K ﹤0.01% 1529
2025
Q1
$577K Sell
205,370
-23,473
-10% -$83.1K ﹤0.01% 1658
2024
Q4
$835K Buy
228,843
+32,574
+17% +$119K ﹤0.01% 1507
2024
Q3
$720K Sell
196,269
-21,273
-10% -$66.1K ﹤0.01% 1580
2024
Q2
$581K Buy
217,542
+89,208
+70% +$250K ﹤0.01% 1643
2024
Q1
$311K Sell
128,334
-43,913
-25% -$147K ﹤0.01% 1943
2023
Q4
$758K Hold
172,247
0.01% 1449
2023
Q3
$773K Sell
172,247
-4,723
-3% -$21.4K 0.01% 1371
2023
Q2
$565K Buy
176,970
+7,152
+4% +$25.8K ﹤0.01% 1618
2023
Q1
$729K Buy
169,818
+6,544
+4% +$37.5K 0.01% 1414
2022
Q4
$1.01M Sell
163,274
-210,390
-56% -$1.17M 0.01% 1209
2022
Q3
$1.92M Sell
373,664
-1,365
-0.4% -$9.1K 0.02% 900
2022
Q2
$2.19M Buy
375,029
+151,529
+68% +$1.27M 0.02% 870
2022
Q1
$2.55M Buy
223,500
+66,759
+43% +$654K 0.02% 892
2021
Q4
$1.35M Buy
156,741
+1,734
+1% +$16.6K 0.01% 1008
2021
Q3
$1.84M Sell
155,007
-4,621
-3% -$52.4K 0.02% 900
2021
Q2
$1.99M Sell
159,628
-4,285
-3% -$60.3K 0.02% 881
2021
Q1
$2.43M Sell
163,913
-9,701
-6% -$131K 0.02% 791
2020
Q4
$2.09M Sell
173,614
-4,793
-3% -$44.3K 0.02% 804
2020
Q3
$1.16M Buy
178,407
+14,787
+9% +$110K 0.01% 961
2020
Q2
$1.32M Buy
163,620
+6,407
+4% +$45.4K 0.02% 919
2020
Q1
$932K Hold
157,213
0.01% 933
2019
Q4
$3.53M Sell
157,213
-1,964
-1% -$43.5K 0.04% 545
2019
Q3
$3.56M Sell
159,177
-3,578
-2% -$84.2K 0.04% 504
2019
Q2
$3.61M Sell
162,755
-5,127
-3% -$110K 0.04% 512
2019
Q1
$3.59M Buy
167,882
+6
+0% +$133 0.04% 515
2018
Q4
$3.63M Buy
167,876
+14,590
+10% +$353K 0.04% 418
2018
Q3
$4M Buy
+153,286
New +$3.93M 0.04% 483

Other funds holding SABR

MetLife Investment Management's SABR Position: Q1 2026 in Review

MetLife Investment Management increased its Sabre (SABR) stake by 19% in Q1 2026, buying an estimated $39.7K and bringing the position to 186,762 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2070.

MetLife Investment Management first reported a position in SABR in Q3 2018 and has held it in 31 quarters since. The position peaked at $4M in Q3 2018. 242 funds tracked by Wall St. Rank hold SABR as of Q1 2026.

  • MetLife Investment Management held 186,762 shares of Sabre worth $271K as of Q1 2026.
  • MetLife Investment Management bought 29,834 Sabre shares in Q1 2026, an estimated $39.7K.
  • Sabre made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2070 holding.
  • MetLife Investment Management first reported a position in Sabre in Q3 2018 and has held it in 31 quarters since.
  • MetLife Investment Management's Sabre position peaked at $4M in Q3 2018.
  • 242 funds tracked by Wall St. Rank held Sabre as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.